These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 22364864)

  • 1. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP; Leary S; Khanna P; Weiss AH
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
    Liu GT; Brodsky MC; Phillips PC; Belasco J; Janss A; Golden JC; Bilaniuk LL; Burson GT; Duhaime AC; Sutton LN
    Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
    Falsini B; Ziccardi L; Lazzareschi I; Ruggiero A; Placentino L; Dickmann A; Liotti L; Piccardi M; Balestrazzi E; Colosimo C; Di Rocco C; Riccardi R
    J Neurooncol; 2008 May; 88(1):87-96. PubMed ID: 18246407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
    Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in 53 patients with cat scratch optic neuropathy.
    Chi SL; Stinnett S; Eggenberger E; Foroozan R; Golnik K; Lee MS; Bhatti MT
    Ophthalmology; 2012 Jan; 119(1):183-7. PubMed ID: 21959368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
    Arvold ND; Lessell S; Bussiere M; Beaudette K; Rizzo JF; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1166-72. PubMed ID: 19406585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1.
    Kelly JP; Weiss AH
    Neuro Oncol; 2013 Nov; 15(11):1560-7. PubMed ID: 24101736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma.
    Paulsen F; Doerr S; Wilhelm H; Becker G; Bamberg M; Classen J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):773-8. PubMed ID: 21300458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical electrophysiology and visual outcome in optic nerve hypoplasia.
    McCulloch DL; Garcia-Filion P; Fink C; Chaplin CA; Borchert MS
    Br J Ophthalmol; 2010 Aug; 94(8):1017-23. PubMed ID: 19955198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Function, Brain Imaging, and Physiological Factors in Children With Asymmetric Nystagmus due to Chiasmal Gliomas.
    Estrada M; Kelly JP; Wright J; Phillips JO; Weiss A
    Pediatr Neurol; 2019 Aug; 97():30-37. PubMed ID: 31113715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.